Clinical isolates of ST131 bla OXA-244-positive Escherichia coli , Italy, December 2022 to July 2023.
Aurora PiazzaMarta CorbellaVittoria Mattioni MarchettiCristina MerlaIrene MiletoAngela KukaGreta PetazzoniStefano GaiarsaRoberta MigliavaccaFausto BaldantiPatrizia CambieriPublished in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2024)
The dissemination of carbapenemase-producing Escherichia coli, although still at low level, should be continuously monitored. OXA-244 is emerging in Europe, mainly in E. coli . In Italy, this carbapenemase was reported from an environmental river sample in 2019. We report clinical isolates of OXA-244-producing ST131 E. coli in four patients admitted to an acute care hospital in Pavia, Italy. The association of this difficult-to-detect determinant with a globally circulating high-risk clone, ST131 E. coli, is of clinical relevance.